Share on StockTwits

Cantel Medical Corp. (NYSE:CMN) CFO Craig A. Sheldon unloaded 8,363 shares of the company’s stock on the open market in a transaction dated Monday, June 23rd. The stock was sold at an average price of $35.90, for a total value of $300,231.70. Following the completion of the transaction, the chief financial officer now directly owns 78,554 shares of the company’s stock, valued at approximately $2,820,089. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Cantel Medical Corp. (NYSE:CMN) traded down 0.03% during mid-day trading on Tuesday, hitting $36.04. The stock had a trading volume of 152,214 shares. Cantel Medical Corp. has a 52-week low of $21.8733 and a 52-week high of $38.04. The stock’s 50-day moving average is $33.56 and its 200-day moving average is $33.4. The company has a market cap of $1.472 billion and a price-to-earnings ratio of 35.00.

Cantel Medical Corp. (NYSE:CMN) last announced its earnings results on Thursday, June 5th. The company reported $0.25 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.26 by $0.01. The company had revenue of $120.06 million for the quarter, compared to the consensus estimate of $117.40 million. During the same quarter last year, the company posted $0.33 earnings per share. Cantel Medical Corp.’s revenue was up 14.4% compared to the same quarter last year. Analysts expect that Cantel Medical Corp. will post $1.08 EPS for the current fiscal year.

The company also recently declared a semiannual dividend, which is scheduled for Thursday, July 31st. Shareholders of record on Thursday, July 17th will be given a dividend of $0.045 per share. This represents a yield of 0.25%. The ex-dividend date of this dividend is Tuesday, July 15th.

Cantel Medical Corp (NYSE:CMN) is a provider of infection prevention and control products and services in the healthcare market.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.